Current position:Home >Product >
2-(6-bromanyl-3-ethanoyl-2-methyl-1-phenyl-indol-5-yl)oxy-N-(2,5-dimethylpyrrol-1-yl)ethanamide
2-(6-bromanyl-3-ethanoyl-2-methyl-1-phenyl-indol-5-yl)oxy-N-(2,5-dimethylpyrrol-1-yl)ethanamide
|
|
Canonical SMILES:
CC1=CC=C(N1NC(=O)COC2=C(C=C3C(=C2)C(=C(N3C4=CC=CC=C4)C)C(=O)C)Br)C
Isomeric SMILES
CC1=CC=C(N1NC(=O)COC2=C(C=C3C(=C2)C(=C(N3C4=CC=CC=C4)C)C(=O)C)Br)C
InChI
InChI=1S/C25H24BrN3O3/c1-15-10-11-16(2)29(15)27-24(31)14-32-23-12-20-22(13-21(23)26)28(17(3)25(20)18(4)30)19-8-6-5-7-9-19/h5-13H,14H2,1-4H3,(H,27,31)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 3-heptyl-5-[1-(triphenylmethyl)-5,6-dihydro-4H-pyrimidin-5-yl]-1,2,4-oxadiazole
- ethyl 4,4,5,5,5-pentakis(fluoranyl)-3-oxidanylidene-2-(triphenyl-$l^{5}-phosphanylidene)pentanoate
- 2-[5-[(2S,4S,5S)-4-azanyl-8-(butylamino)-7-methyl-5-oxidanyl-8-oxidanylidene-2-propan-2-yl-octyl]-2-tert-butyl-phenoxy]ethanoic acid
- N-[4-[(6-chloranyl-2-methoxy-acridin-9-yl)amino]-3-methoxy-phenyl]methanesulfonamide hydrochloride
- (3S,6S,8R,9R,10R,12R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2S,5R)-2,6,6-trimethyl-5-oxidanyl-oxan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol
- N-[4-[(6-chloranyl-2-methoxy-acridin-9-yl)amino]-3-methoxy-phenyl]methanesulfonamide
- 6-chloranyl-9-[(1R,2R)-3-methylidene-2-[(triphenylmethyl)oxymethyl]cyclobutyl]purine
- 1'-[3-(9-chloranyl-3-oxidanyl-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]spiro[5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-3,4'-piperidine]-2-one
- 4-bromanyl-N-[(2R)-3-[4-(oxidanylamino)-4-oxidanylidene-butyl]sulfanyl-1-oxidanylidene-1-[(phenylmethyl)amino]propan-2-yl]benzamide
- 1-[(4-chlorophenyl)methyl]-2-[4-(diphenylmethyl)piperazin-1-yl]benzimidazole

